Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For the past five months (November 2012 - March 2013):
VFIN's monthly share volume has been:
Nov: 50.8 M
Dec: 282 M
Jan: 143.6 M
Feb: 2.7 M
Mar: 119.6 M
Total: 598.7 M
VNDM's monthly share volume has been:
Nov: 11.8 M
Dec: 77.3 M
Jan: 34.4 M
Feb: ZERO
Mar: 96.7 M
Total: 220.2M
Looks like they are finally done. Take it for what it is worth!
$157+K $ for that 23+ M at ask.
Perception is everything with this company. $72+K $ just bought 10.5 M @ .0069. Somebody believes.
8-K out stating official de-listing from BBSE.
AMBS BBSE De-listing
50% of yesterday's volume was short.
Honestly, I could NOT DISAGREE more.
Counting the 2:01 PM trade, approximately 2.68 M shares traded during the last two hours in 35 trades. A very low-volume two-hour period for BMSN. This was nothing more than continued manipulation to get shares from the weak.
A lot of inexperienced people lose money daily in the stock market because of an instant lottery ticket mentality. Identify your risk tolerance and invest accordingly. Bank CDs/Money Market Accounts may prove more to the liking (i.e., tolerance level) of many.
BMSN is going to make a lot of people a lot of money in the very near future. In doing quality DD, it is not just doing research on the company. If you are going to listen to others (or allow them to influence your decisions), you should do as much DD on who you are listening to as well as the company you are investing in.
About 60% (3 M) of today's volume in 11 trades. The remaining 2.2 M in 84 trades...about 26,000 average shares/trade. Nothing but MM games and flippers.
From news release:
The Company's ticker symbol will remain unchanged, although a "D" will be placed on the ticker symbol, LUXD, for 20 business days to alert the public to the Reverse Split.
Compliments of stervc:
BMSN Valuations & Orphan Drug Thoughts
Perhaps you should have read the info on that page.
Paying debts is hardly dilution. From the 10-k:
Only ones selling are those who really do not grasp what is in front of them and those who are trying to entice "fear" into others so they can buy more.
Smart money knows what this means and what they own.
Long BMSN
From this morning's PR:
An intelligent and very well articulated post. Lots of quality FACTS there. Thanks!
Long BMSN
ALL news is NOT the same. People NEED TO UNDERSTAND the value of the news.
Long BMSN
From 10-K:
When the last 911 trade came out (about the time as the 10-K hitting the wires), BMSN had traded 61.5 M shares and sat at .0145.
Then, after a bit of fun running down to .0091, it turned back GREEN at 77.3 M shares @ 3:48. Less than 16 M shares took it from .0145 to .0091 and back up to .0135. You have to love trading the OTC market.
They put out the 10-K when they did for a reason. Tomorrow big IND news and BMSN takes flight.
Get some rest.
People let some noise and 6M in selloff shares scare them out of an amazing opportunity. Oh well, live and learn. Trading in the OTC market is not for the faint of heart or inexperienced.
For those wondering where the yellow stickies went...
IH Geek Dave post of 2/28/13
For those wondering where the yellow stickies went...
IH Geek Dave post of 2/28/13
For those wondering where the yellow stickies went...
IH Geek Dave post #164584 of 2/28/13
Entest BioMedical, Inc. Sees Entry Into $300 Million Veterinary Cancer Care Market Through Veterinary Hospital Acquisitions
9/4/12 PR
WHY ENTB?
Complements of moneyduh #20014 (2/15/13 @ 4:27:31 PM):
TBI Joint Poster Presentation
Complements of StockDog #61014 (2/26/13 @ 11:25:59 AM):
AMBS ~ BANYAN AND AMARANTUS presentation March 6-7
Amarantus BioScience, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced that the companies will be making a joint poster presentation March 6-7, 2013 at The 3rd Annual Traumatic Brain Injury (TBI) Conference in Washington, DC (www.tbiconference.com). The poster is entitled "Mesencephalic astrocyte-derived neurotrophic factor (MANF) neuroprotection from necrotic and apoptotic cell death in rat cortical cultures."
"MANF significantly inhibited caspase and calpain-mediated cellular processes of cell death and conferred overall neuroprotection in our cellular model systems of TBI," said Dr. Juan Martinez, Director of Scientific Operations at Banyan Biomarkers. "This neuroprotection indicates therapeutic potential based on well-defined biochemical pathway inhibition. We look forward to working with Amarantus to further develop MANF's therapeutic potential in TBI."
AMBS TBI
BMSN - Why a quick FDA Orphan Drug Approval…
Complements of stervc #35586 of 2/19/13 (8:57:26 AM):
BMSN
Lowest volume day since 12/19.
MAXM is a market maker. They are traditionally a non-retail marker maker, which means they don't work with small investors like you and me. They typically work with companies and large investors. They deal more in big board stocks.
MAXM
Average PPS: .01039
Low volume continues with average shares per trade about 97k.
Considering the number of trades for more than 300k shares, majority of today's trades have either been by small $ traders or MM games.
Long BMSN
Light volume and small share trade lots. Less than 85K shares per trade average.
IND and Orphan Drug are not the same.
IND Application
Orphan Drug
After several days of lower than average short volume (3 days under 20%), yesterday's short volume climbed to 26.75%.
After watching today's trading, I bet we see 45%+ tomorrow as today's short volume.
AMBS Short Selling Report
YEARS LONG AMBS
Volume for the last month (1/22 - 2/20/13, 22 trading days):
Total: 133 M (45 M, 33.8%, on THREE DAYS, 1/22, 1/23 & 2/7)
Average (all 22 days): 6 M
Average (not including THREE "high" volume days): 4.9 M
This tells me flippers, shorts and those with much shorter time horizons (hours, days, weeks) are doing most of the selling, not the longs (believers) who know what they own. Also, a significant portion of the daily volume is probably being added to the already sizeable holdings of longs.
Also notice how many longs have stopped posting (or have considerably cut back on their posts) because the daily fluctuations in PPS are immaterial when your time horizon is measured in months or years.
26 slides from the 2/11/13 CEO & Investor Conference are now available at 2013 CEO & Investor Conference
YEARS LONG AMBS
Re website...after being down for some time, when I go to BMSN, it comes up on the Regen Biopharma website.
Over the past three weeks (1/22 - 2/15), BMSN has had a 39.4% average daily short volume.
Short Selling Report
Dumping is just NOT a good word for what is happening as this stock continues to move upward.
The MJFF Hot Topics Webinar today is discussing the status of PD Research in general and not specifics about any new/upcoming grants, per se.
From the MJFF website:
Golden cross! Both at .0032.
Still watching.
For a whopping $13.49.